Diverse phenotypic and genotypic presentation of RAG1 mutations in two cases with SCID
dc.contributor.author | Karaca, Neslihan Edeer | |
dc.contributor.author | Aksu, Guzide | |
dc.contributor.author | Genel, Ferah | |
dc.contributor.author | Gulez, Nesrin | |
dc.contributor.author | Can, Sema | |
dc.contributor.author | Aydinok, Yesim | |
dc.contributor.author | Aksoylar, Serap | |
dc.contributor.author | Karaca, Emin | |
dc.contributor.author | Altuglu, Imren | |
dc.contributor.author | Kutukculer, Necil | |
dc.date.accessioned | 2019-10-27T21:19:04Z | |
dc.date.available | 2019-10-27T21:19:04Z | |
dc.date.issued | 2009 | |
dc.department | Ege Üniversitesi | en_US |
dc.description.abstract | Severe combined immunodeficiencies (SCID) comprise a spectrum of genetic defects that involve both humoral and cellular immunities. Defects in recombinating activating gene 1 (RAG1), RAG2, Artemis, or LIG4 can disrupt V(D)J recombination. Defective V(D)J recombination of the T and B cell receptors is responsible for T(-)B(-)NK(+)SCID. Amorphic mutations in RAG1 and RAG2 cause T(-)B(-)NK(+)SCID, whereas hypomorphic mutations cause an immunodeficency characterized by oligoclonal expansion of TCR gamma delta T cells, severe CMV infection and autoimmunity. First patient is a typical T(-)B(-)NK(+)SCID with clinical and immunologic findings while the second is atypical with normal immunoglobulin levels, CD4 lymphopenia, elevated TCR gamma delta T cells, persistent CMV infection, and autoimmune hemolytic anemia. These cases are presented to emphasize that mutations in RAG1 gene may lead to a diverse spectrum of clinical and immunologic findings while hypomorphic mutations may be related with autoimmunity and refractory CMV infection during infancy. | en_US |
dc.identifier.doi | 10.1007/s10238-009-0053-1 | en_US |
dc.identifier.endpage | 342 | en_US |
dc.identifier.issn | 1591-8890 | |
dc.identifier.issue | 4 | en_US |
dc.identifier.pmid | 19458910 | en_US |
dc.identifier.scopusquality | Q1 | en_US |
dc.identifier.startpage | 339 | en_US |
dc.identifier.uri | https://doi.org/10.1007/s10238-009-0053-1 | |
dc.identifier.uri | https://hdl.handle.net/11454/44090 | |
dc.identifier.volume | 9 | en_US |
dc.identifier.wos | WOS:000270648500014 | en_US |
dc.identifier.wosquality | Q3 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Springer | en_US |
dc.relation.ispartof | Clinical and Experimental Medicine | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | RAG1 mutations | en_US |
dc.subject | CMV | en_US |
dc.subject | Autoimmunity | en_US |
dc.subject | Immunodeficiency | en_US |
dc.title | Diverse phenotypic and genotypic presentation of RAG1 mutations in two cases with SCID | en_US |
dc.type | Article | en_US |